Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications.

X box-binding protein 1 (Xbp-1) is a transcription factor that is required for the terminal differentiation of B lymphocytes into plasma cells. The Xbp-1 gene is activated in response to endoplasmic reticulum stress signals, which generate a 50-kDa nuclear protein that acts as a potent transactivator and regulates the expression of genes related to the unfolded protein response. Activated Xbp-1 is essential for cell survival in plasma-cell tumors but its role in B-cell lymphomas is unknown. We analyzed the expression of activated Xbp-1 in reactive lymphoid tissues, 411 lymphomas and plasma-cell neoplasms, and 24 B-cell lines. In reactive tissues, Xbp-1 was only found in nuclear extracts. Nuclear expression of Xbp-1 was observed in occasional reactive plasma cells and in a subpopulation of Irf-4(+)/Bcl-6(-)/Pax-5(-) B cells in the light zones of reactive germinal centers, probably representing cells committed to plasma-cell differentiation. None of the low-grade lymphomas showed evidence of Xbp-1 activation; however, Xbp-1 activation was found in 28% of diffuse large B-cell lymphomas, independent of germinal or postgerminal center phenotype, as well as in 48% of plasmablastic lymphomas and 69% of plasma-cell neoplasms. Diffuse large B-cell lymphomas with nuclear Xbp-1 expression had a significantly worse response to therapy and shorter overall survival compared with negative tumors. These findings suggest that Xbp-1 activation may play a role in the pathogenesis of aggressive B-cell lymphomas.

[1]  Antonio Martínez,et al.  Expression of the Interferon Regulatory Factor 8/ICSBP-1 in Human Reactive Lymphoid Tissues and B-cell Lymphomas: A Novel Germinal Center Marker , 2008, The American journal of surgical pathology.

[2]  P. Rudland,et al.  Expression and splicing of the unfolded protein response gene XBP‐1 are significantly associated with clinical outcome of endocrine‐treated breast cancer , 2008, International journal of cancer.

[3]  Y. Teng,et al.  IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells. , 2007, European journal of cell biology.

[4]  Hua Jiang,et al.  Coordination of upregulated XBP-1 and downregulated c-myc during myeloma cell differentiation induced by 2-methoxyestradiol. , 2007, Leukemia research.

[5]  A. Protopopov,et al.  The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma Pathogenesis , 2007, Cancer cell.

[6]  T. Sugihara,et al.  Establishment of five human myeloma cell lines , 1989, In Vitro Cellular & Developmental Biology.

[7]  W. Chan,et al.  Mantle Cell Lymphoma With Plasma Cell Differentiation , 2006, The American journal of surgical pathology.

[8]  Qiong Shen,et al.  Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination , 2006, Nature Immunology.

[9]  M. Busslinger,et al.  Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. , 2006, Immunity.

[10]  S. Swerdlow,et al.  The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. , 2006, Human pathology.

[11]  Y. Okuno,et al.  Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells , 2006, Leukemia & lymphoma.

[12]  Gerald C. Chu,et al.  XBP‐1 is required for biogenesis of cellular secretory machinery of exocrine glands , 2005, The EMBO journal.

[13]  Antonio Martínez,et al.  Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors. , 2005, Blood.

[14]  K. Mori,et al.  A role for the unfolded protein response in optimizing antibody secretion. , 2004, Molecular immunology.

[15]  L. Staudt,et al.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.

[16]  R. Kaufman,et al.  A trip to the ER: coping with stress. , 2004, Trends in cell biology.

[17]  L. Glimcher,et al.  XBP-1 Regulates a Subset of Endoplasmic Reticulum Resident Chaperone Genes in the Unfolded Protein Response , 2003, Molecular and Cellular Biology.

[18]  R. Sitia,et al.  The Making of a Professional Secretory Cell: Architectural and Functional Changes in the ER during B Lymphocyte Plasma Cell Differentiation , 2003, Biological chemistry.

[19]  Paul Kellam,et al.  Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Neal N. Iwakoshi,et al.  Proteasome inhibitors disrupt the unfolded protein response in myeloma cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  L. Glimcher,et al.  The X‐box binding protein‐1 transcription factor is required for plasma cell differentiation and the unfolded protein response , 2003, Immunological reviews.

[22]  R. Dalla‐Favera,et al.  Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. , 2003, Blood.

[23]  K. Rajewsky,et al.  Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1 , 2003, Nature Immunology.

[24]  M. Schebesta,et al.  Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. , 2002, Immunity.

[25]  Hiderou Yoshida,et al.  IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. , 2002, Genes & development.

[26]  Stevan R. Hubbard,et al.  IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA , 2002, Nature.

[27]  K. Mori,et al.  XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription Factor , 2001, Cell.

[28]  K. Mori,et al.  Identification of the G13 (cAMP-response-element-binding protein-related protein) gene product related to activating transcription factor 6 as a transcriptional activator of the mammalian unfolded protein response , 2001 .

[29]  K. Mori,et al.  Identification of the G13 (cAMP-response-element-binding protein-related protein) gene product related to activating transcription factor 6 as a transcriptional activator of the mammalian unfolded protein response. , 2001, The Biochemical journal.

[30]  R. Kaufman,et al.  Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. , 2000, The Journal of biological chemistry.

[31]  H Stein,et al.  A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. , 2000, Blood.

[32]  S. Orkin,et al.  An essential role in liver development for transcription factor XBP-1. , 2000, Genes & development.

[33]  K. Mori,et al.  Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. , 1999, Molecular biology of the cell.

[34]  J. Brodsky,et al.  ER protein quality control and proteasome-mediated protein degradation. , 1999, Seminars in cell & developmental biology.

[35]  R. Kaufman,et al.  The cellular response to protein misfolding in the endoplasmic reticulum. , 1999, Gene expression.

[36]  T. Kita,et al.  Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype. , 1997, Journal of immunology.

[37]  Yau-Tsun Steven Li,et al.  Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1 , 1996, The Journal of experimental medicine.

[38]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[39]  J. Diebold,et al.  Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors. , 1991, Archives of pathology & laboratory medicine.

[40]  S. Tarui,et al.  Two distinct human myeloma cell lines originating from one patient with myeloma , 1985, International journal of cancer.